Neogen Corporation
NASDAQ:NEOGMedical - Diagnostics & Research
+$0.16 today
- Market cap
- $2.42B
- Beta
- 1.80
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$2.80
Volume 1.79M
Average 2.53M
NEOG Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Neogen CorporationNASDAQ: NEOG
Operating Margin · Q1 FY2027 · quarter ended Aug 2026
Operating margin widens to -0.8%
Operating margin was -0.8% in Q1 FY2027, up 6.9 pp from a year earlier. On a trailing-twelve-month basis it was -0.8%, down 0.8 pp year over year. Over 3 fiscal years it narrowed by 7.0 pp.
Context
- Operating margin widened in 1 of the last 3 fiscal years.
- FY2026 was the lowest level in the 4 fiscal years shown.
What to watch
Whether operating margin reaches the consensus estimate from 4 analysts of 16.8% for the fiscal year ending May 2027, up from -2.5% in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterAug 2026
- -0.8%-2.2 pp QoQ
- Last fiscal yearMay 2026
- -2.5%-3.5 pp YoY
- LTMAug 2026
- -0.8%-0.8 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2026
- -2.5%
- Year-over-year change
- -3.5pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2026 | 2026-05-31 | -2.5% | -3.5pp |
| FY2025 | 2025-05-31 | 1.1% | -7.3pp |
| FY2024 | 2024-05-31 | 8.4% | +3.8pp |
| FY2023 | 2023-05-31 | 4.6% | -6.6pp |
| FY2022 | 2022-05-31 | 11.1% | — |
Operating Margin vs competitors
How NEOG compares with its peers on the latest reported figures
- NEOG's LTM Aug 2026 operating margin of -0.8% is the lowest of the 7 companies compared; the peer median is 19.0%.
- Its year-over-year change of -0.8 pp is the 6th highest of 7, against a peer median of +1.1 pp.
- Over three fiscal years its change of -7.0 pp compares with a peer median of +3.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 37.0% | -0.5 pp | +1.8 pp | |
| LTM Sep 2026 | 32.3% | +1.0 pp | +4.9 pp | |
| LTM Sep 2026 | 21.4% | +1.2 pp | +5.6 pp | |
| LTM Jun 2026 | 16.7% | -16.9 pp | +5.3 pp | |
| LTM Mar 2026 | 12.3% | +4.3 pp | +0.1 pp | |
| LTM Sep 2026 | 10.0% | +4.8 pp | -3.4 pp | |
| LTM Aug 2026 | -0.8% | -0.8 pp | -7.0 pp | |
| Peer median (excluding NEOG) | 19.0% | +1.1 pp | +3.3 pp | |
Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 May 2022 | FY2023 May 2023 | FY2024 May 2024 | FY2025 May 2025 | FY2026 May 2026 |
|---|---|---|---|---|---|
| Revenue | 527.16M | 822.45M | 924.22M | 894.66M | 870.4M |
| Cost of Revenue | 284.15M | 416.49M | 461.59M | 473.29M | 461.9M |
| Gross Profit | 243.01M | 405.96M | 462.64M | 421.38M | 408.5M |
| Gross Margin | 46.1% | 49.4% | 50.1% | 47.1% | 46.9% |
| Research & Development | 17.05M | 26.04M | 22.48M | 21.09M | 18.4M |
| Selling, General & Admin | 167.35M | 342.4M | 382.76M | 401.97M | 411.7M |
| Operating Expenses | 184.4M | 368.44M | 385.21M | 411.96M | 430.1M |
| Depreciation & Amortization | 24.13M | 90.47M | 121.23M | 125.67M | 116.3M |
| EBITDA | 84.34M | 124.39M | 182.6M | (937.75M) | 164.9M |
| EBITDA Margin | 16.0% | 15.1% | 19.8% | -104.8% | 18.9% |
| Operating Income | 58.62M | 37.52M | 77.43M | 9.42M | (21.6M) |
| Operating Margin | 11.1% | 4.6% | 8.4% | 1.1% | -2.5% |
| Interest Income | 1.34M | 3.17M | 6.36M | 3.11M | 0 |
| Interest Expense | 72K | 55.96M | 73.39M | 71.62M | 57.6M |
| Other Income / Expenses | 1.59M | (59.56M) | (91.73M) | (1.14B) | 12.6M |
| Income Before Tax | 60.21M | (22.04M) | (14.31M) | (1.13B) | (9M) |
| Pre-Tax Margin | 11.4% | -2.7% | -1.5% | -126.7% | -1.0% |
| Income Tax Expense | 11.9M | 828K | (4.88M) | (41.07M) | (1.1M) |
| Net Income | 48.31M | (22.87M) | (9.42M) | (1.09B) | (7.9M) |
| Net Margin | 9.2% | -2.8% | -1.0% | -122.1% | -0.9% |
| EPS (Basic) | 0.45 | (0.12) | (0.04) | (5.03) | (0.04) |
| EPS (Diluted) | 0.45 | (0.12) | (0.04) | (5.03) | (0.04) |
| Weighted Avg Shares | 107.68M | 188.88M | 216.48M | 216.89M | 217.5M |
| Weighted Avg Shares (Diluted) | 108.02M | 188.88M | 216.48M | 216.89M | 217.5M |
Neogen Corporation
NASDAQ:NEOG
Intrinsic Alpha fair value
Locked
Current Price
$11.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.